Akebia Therapeutics, Inc. (AKBA)
0.865
-0.01
(-0.69%)
USD |
NASDAQ |
Oct 02, 16:00
0.85
-0.02
(-1.73%)
After-Hours: 20:00
Akebia Therapeutics Price to Book Value : 9.395 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 9.395 |
| October 01, 2026 | 9.460 |
| September 30, 2026 | 9.992 |
| September 29, 2026 | 9.624 |
| September 28, 2026 | 9.700 |
| September 25, 2026 | 9.734 |
| September 24, 2026 | 9.982 |
| September 23, 2026 | 10.13 |
| September 22, 2026 | 10.64 |
| September 21, 2026 | 10.19 |
| September 18, 2026 | 9.946 |
| September 17, 2026 | 9.726 |
| September 16, 2026 | 9.968 |
| September 15, 2026 | 9.808 |
| September 14, 2026 | 10.46 |
| September 11, 2026 | 10.34 |
| September 10, 2026 | 10.28 |
| September 09, 2026 | 10.36 |
| September 08, 2026 | 11.19 |
| September 04, 2026 | 10.59 |
| September 03, 2026 | 10.68 |
| September 02, 2026 | 10.65 |
| September 01, 2026 | 10.26 |
| August 31, 2026 | 9.979 |
| August 28, 2026 | 9.543 |
| Date | Value |
|---|---|
| August 27, 2026 | 10.21 |
| August 26, 2026 | 9.846 |
| August 25, 2026 | 10.41 |
| August 24, 2026 | 9.782 |
| August 21, 2026 | 9.847 |
| August 20, 2026 | 9.986 |
| August 19, 2026 | 9.617 |
| August 18, 2026 | 9.252 |
| August 17, 2026 | 9.341 |
| August 14, 2026 | 9.480 |
| August 13, 2026 | 9.445 |
| August 12, 2026 | 9.701 |
| August 11, 2026 | 9.411 |
| August 10, 2026 | 9.167 |
| August 07, 2026 | 9.883 |
| August 06, 2026 | 10.37 |
| August 05, 2026 | 14.01 |
| August 04, 2026 | 14.34 |
| August 03, 2026 | 14.23 |
| July 31, 2026 | 14.34 |
| July 30, 2026 | 14.66 |
| July 29, 2026 | 13.69 |
| July 28, 2026 | 13.79 |
| July 27, 2026 | 13.90 |
| July 24, 2026 | 13.25 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Emergent BioSolutions, Inc. | 0.9512 |
| Exelixis, Inc. | 7.882 |
| ADMA Biologics, Inc. | 5.366 |
| Arcutis Biotherapeutics, Inc. | 14.33 |
| Relay Therapeutics, Inc. | 4.655 |
Price to Book Value Related Metrics
| PS Ratio | 1.063 |
| Price to Free Cash Flow | 5.781 |
| Price | 0.865 |
| Earnings Yield | -12.83% |
| Market Cap | 235.06M |